(Q35721939)

9 August 2017

1 reference

title

Can amodiaquine be used safely during pregnancy? (English)

1 reference

9 August 2017

0 references

3

Umberto D'Alessandro

1 reference

9 August 2017

Florence Thomas

1

1 reference

PubMed ID

15050942

9 August 2017

Annette Erhart

series ordinal

2

1 reference

9 August 2017

1 April 2004

1 reference

Lancet Infectious Diseases

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

235-239

1 reference

9 August 2017

4

1 reference

Camoquin in the treatment of human malaria.

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

A 15 month controlled study of the effects of amodiaquine (camoquin) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

The effect of amodiaquin (camoquin) on the course of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Effect of disposition of mannich antimalarial agents on their pharmacology and toxicology.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Fatal agranulocytosis during treatment with a amodiaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Amodiaquine and hydroxychloroquine in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Amodiaquine induced agranulocytosis and liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

The mechanism of bioactivation and antigen formation of amodiaquine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Influence of amodiaquine treatment on microsomal lipid peroxidation and antioxidant defense systems of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitaemia and placental infection in pregnant women in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Editorial: Maternal malaria: time for action.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2900974-0

7 January 2021

10.1016/S1473-3099(04)00974-0

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15050942